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LOCAL MICROWAVE HYPERTHERMIA IN CANCER THERAPY. PRELIMINARY REPORT
Carlos A. Perez, M.D., Walter Kopecky, Ph.D., Robert Baglan, M.D.
D. Venkata Rao, M.D. and Richard Johnson, M.D.*
Washington University School of Medicine, Roswell Park Memorial Institute*
and the Radiation Therapy Oncology Group
Summary
This report summarizes the preliminary experience on 26 patients treated at the
Mallinckrodt Institute of Radiology with hyperthermia and irradiation. Patients were
treated with 400 rad fractions given every 72 hours (twice weekly) for a total of 2400,
2800, 3200 or 4000 rad followed by hyperthermia. In addition 18 lesions were treated
according to a protocol designed by the Radiation Therapy Oncology Group (RTOG) for
superficial measurable tumors randomized lesions to receive three doses of 500 rad
followed by hyperthermia (6 lesions), or irradiation alone (three doses of 600, 700 or
800 rad every 72 hours.
Hyperthermia was administered with 2450 MHz or 915 MHz microwave generators and
appropriately designed surface applicators. Temperature used was 42.5°-43° C, 90 minutes,
every 72 hours. Irradiation was delivered with varying energy electrons (12 to 16 Mev)
as required by the size of the lesion and occasionally with Cobalt 60 in which case bolus
was used to increase the surface dose.
Of the six lesions treated with 1500 rad and hyperthermia only two metastatic
melanomas showed complete regression, three tumors exhibited partial regression (one
metastatic epidermoid carcinoma in the abdominal wall, a melanoma and a recurrent ductal
breast carcinoma of the chest wall). The two melanoma nodules with CR remained under
control for 12 and 16 months after therapy. A metastatic melanoma nodule showed no
significant regression. Nine of the 12 control lesions treated with radiotherapy alone,
mostly melanoma or recurrent carcinoma of the breast showed complete regression after
doses of irradiation alone varying from 1800 to 2400 in three fractions. The other three
lesions had 50% or more regression of the tumor. Some of the patients had control of the
lesions for 12 to 16 months after therapy. I t was apparent that 1500 rad and hyperthermia
were not as effective as higher doses of irradiation alone.
The patients
hyperthermia) had
adenocarcinoma of
4000 to 6000 rad;

treated on the intramural protocol (doses of 2400 to 4000 rad and
recurrent lesions from epidermoid carcinoma of the head and neck or
the breast, most of them previously irradiated with doses ranging from
other tumors included several metastatic melanoma nodules.

Four of six recurrent epidermoid carcinoma of the head and neck showed complete
regression and two others 20 and 40% regression. Of three metastatic melanoma nodules
treated with irradiation and hyperthermia two showed complete regression of the tumors
and over 80% regression, all lasting from five to eight months.
Of eight recurrent adenocarcinoma of the breast nodules in the chest wall, two were
treated with doses of 2000 rad and showed only minimal regression of the tumor and regrew
within two months from treatment. This is contrasted with six other lesions, treated with
eight or 10 fractions of 400 rad each; four lesions exhibiting complete regression and the
other two about 80%, with a duration of about three months.
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Further, three patients with rather extensive recurrent adenocarcinoma of the breast
in the chest wall were treated with heat alone because of high doses of irradiation
delivered previously, only minimal tumor regression was noted (less than 25%). One
patient with recurrent laryngeal carcinoma in the neck treated with heat alone exhibited
complete tumor regression, s t i l l present, 18 months after hyperthermia.
The doses of radiation and heat delivered have been extremely well tolerated by the
normal tissues. Of the 34 sites treated, three (8%) developed blisters, three (8%)
erythema only, three additional patients (8%) moist desquamation and 14 (41%) dry
desquamation. There have been no instances of ulceration, necrosis or severe fibrosis
in the treated areas, even in the patients surviving over one year.
In view of these preliminary observations we feel that additional clinical trials are
warranted to assess the potential value of hyperthermia alone or combined with irradiation
in the treatment of selected cancer patients. Intensive efforts will be immediately
required to improve existing methods for delivery and measurement of heat to lesions
located at more than 5 cm depth.
Introduction
Probably the f i r s t observation that heat has an effect on malignant cells was reported
by Bush (1), who described the disappearance of a sarcoma following high fever in a patient
with erysipela. Despite encouraging reports by Coley (2) using bacterial toxins to induce
fever and Westermark (3), who used localized hyperthermia followed by two publications by
Rohdenburg, 1918 (4) and Warren in 1935 (5) hyperthermia in the treatment of malignant
disease has had minimal clinical application (6,7,8,9).
In the past 10 years there has been a renewed interest in this modality, with a large
number of biological papers indicating that there may be significant advantages to the use
of heat alone or combined with irradiation or cytotoxic drugs to enhance the killing of
tumor cells (10,11,12).
The clinical use of localized or whole body heat has been severely hampered by the
lack of adequate equipment to deliver effective heat in deep seated lesions and of
thermometry techniques that may provide reliable information regarding the distribution of
the heat in the target tissues. However, a number of institutions throughout the world
have begun to utilize several modalities of heating (radiofrequency, microwave or ultrasound) in an effort to gain information relative to the tolerance of normal tissues and
the optimal parameters of hyperthermia alone or combined with radiation to enhance tumor
cell k i l l without damaging normal tissues.
The following is a report of preliminary observations accumulated at the Mallinckrodt
Institute of Radiology in a selected group of patients with recurrent or metastatic
superficial nodules treated over a two year period (1978-1979).
Materials and Methods
In 1978 and 1979 a total of 26 superficial tumors were treated at the Mallinckrodt
Institute of Radiology with hyperthermia and irradiation.
The doses of irradiation consisted of 400 rad fractions given every 72 hours (twice
weekly) for a total of 2400, 2800, 3200 or 4000 rad, in a dose seeking experiment to
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assess tolerance of normal tissues and tumor response (3 to 5 patients per dose).
In addition 18 lesions were treated according to a protocol designed by the Radiation
Therapy Oncology Group (RTOG) for superficial measurable tumors randomized lesions to
receive three doses of 500 rad followed by hyperthermia (43° C, 90 minutes, every 72 hours)
or irradiation alone (three doses of 600, 700 or 800 rad every 72 hours).
Further, two recurrent nodules of head and neck epidermoid carcinoma and three
extensive recurrences from carcinoma of the breast in the chest wall were treated with
heat alone.
The equipment and techniques of heating as well as thermometry have been previously
described (13). Microwave generators (2450 and 915 MHz) with specially designed
applicators were used. Thermocouples were inserted at the depth of the tumor and over the
skin surface and the temperature at these two sites was continuously recorded on a dual
channel chart recorder.
Irradiation was delivered with varying energy electrons (12 to 16 Mev) as required by
the size of the lesion and occasionally with Cobalt 60 in which case bolus was used to
increase the surface dose.
Resul ts
1. RTOG protocol 77-10.
Of the six lesions treated in this protocol with irradiation and hyperthermia, two
metastatic melanomas showed complete regression, three tumors exhibited partial regression
(one metastatic epidermoid carcinoma in the abdominal wall, a melanoma and a recurrent
ductal breast carcinoma of the chest wall). The two melanoma nodules with CR remained
under control for 12 and 16 months after therapy. A metastatic melanoma nodule showed no
significant regression.
Some of the lesions probably did not show clinical regression because the patients
were in a terminal state and died within weeks from therapy.
Nine of the 12 control lesions treated with radiotherapy alone, mostly melanoma or
recurrent carcinoma of the breast showed complete regression after doses of irradiation
alone varying from 1800 to 2400 in three fractions. The other three lesions had 50% or
more regression of the tumor. Some of the patients had control of the lesions for 12 to
16 months after therapy.
I t was apparent from this study that 1500 rad and hyperthermia were not as effective
as higher doses of irradiation. On this basis, an intramural protocol was initiated which
delivered higher doses of irradiation.
2.

Intramural protocol.

The patients treated on the Washington University intramural protocol had recurrent
lesions from epidermoid carcinoma of the head and neck or adenocarcinoma of the breast
most of which had been previously irradiated with doses ranging from 4000 to 6000 rad,
other tumors included several metastatic melanoma nodules (Tables 1 and 2).
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Four of s i x recurrent epidermoid carcinoma of the head and neck showed complete
regression and two others 20 and 40% regression. Of three metastatic melanoma nodules
treated with i r r a d i a t i o n and hyperthermia two showed complete regression of the tumors
and one 80% regression, a l l l a s t i n g from f i v e to eight months.
One o f the patients treated with heat alone showed complete regression of a
4 X 3 X 1 cm subcutaneous nodule with s u p e r f i c i a l u l c e r a t i o n of the l e f t neck which
appeared f o l l o w i n g IJ^ years a f t e r d e l i v e r y of 5700 rad TD to the neck with Cobalt 60 and
s u p r a g l o t t i c laryngectomy. The p a t i e n t remains free of disease 15 months a f t e r therapy.
Another p a t i e n t , with a 7 x 3 x 5 x . 5 c m recurrent epidermoid carcinoma of the scalp was
treated with heat alone. Most of the tumor underwent complete regression but p e r s i s t e n t
nodule at the margin was treated with 4500 rad TD i n 15 f r a c t i o n s , three weeks with
s u p e r f i c i a l x-rays (120 KV, .3 mm cu HVL). He died eight months l a t e r with l i v e r
c i r r h o s i s ; there was no evidence of recurrent tumor ( F i g . l A , I B ) .
Of the three metastatic melanoma nodules, treated with i r r a d i a t i o n and hyperthermia
two showed complete regression of the tumors, which lasted from f i v e to 10 months. One
of the patients had two lesions ( F i g . 2A, 2B); one was treated with i r r a d i a t i o n (5000 rad)
and hyperthermia, with p r a c t i c a l l y complete regression, which lasted f o r eight months.
The p a t i e n t died with widespread metastases. The second l e s i o n was treated with i r r a d i a t i o n
alone (as control s i t e ) ; a regression of 75% was noted, with regrowth w i t h i n s i x months
of therapy ( F i g . 3 ) .
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Graph showing tumor regression of several metastatic
melanoma nodules.
Of eight recurrent adenocarcinoma of the breast lesions in the chest wall, two were
treated with doses of 2000 rad and they showed only minimal regression of the tumor and
regrew within two months from treatment. This is contrasted with six other lesions,
treated with eight or 10 fractions of 400 rad each, four lesions exhibiting 100%
regression and the other two 80% response, with a duraction of about three months.
In the three patients with rather extensive recurrent adenocarcinoma of the breast
and the chest wall treated with heat alone because of high doses of irradiation delivered
previously, only minimal regression was noted (less than 25%).
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Normal tissue reactions
The doses of radiation and heat have been extremely well tolerated by the normal
tissues. Of the 34 sites treated, three (8%) developed blisters, three (8%) erythema
only, three additional patients (8%) moist desquamation and 14 (41%) dry desquamation.
This is in contrast to the patients treated with irradiation alone, three of whom
developed moist desquamation with doses of 2100 and 2400 rad in three fractions (5%).
There have been no instances of ulceration, necrosis or severe fibrosis in the
treated areas, even in the patients surviving over one year.
The degree of fibrosis existing at the time of the irradiation and hyperthermia, due
to previous radiotherapy has not been aggravated by the additional hyperthermia and
irradiation treatment.
Discussion
In vitro and in vivo biological experiments suggest that heat may be more damaging to
tumor than to normal cells because of a variety of reasons, which include 1) reduced blood
supply in the tumor, 2) possible Inherent Increased sensitivity of hypoxic cells to heat
and 3) metabolically deprived tumor cells with reduced pH. In addition, heat affects
cells in "S" phase, which are known to be resistant to irradiation (10,11,14).
The sensitivity of hypoxic cells to heat is complicated by the possible association
of low oxygen tension with nutrient deficiency or reduced pH. As pointed out by Dewey
(11) this response of the tumor may be complicated by physiological changes associated
with lowering In blood flow and oxygen tension produced by the hyperthermia.
Heat causes a greater degree of mitotic delay than irradiation, and this factor may
affect the distribution of cells in the cell cycle after heat or x-rays (15,16).
Experiments are being conducted at the present time to separate the thermal from the
nonthermal effects produced by some of the heating modalities used, such as ultrasound
and radiofrequency hyperthermia.
I t Is Important to gather information concerning the effects of heat alone or combined
with irradiation or cytotoxic agents on human tumors. Also, of equal significance are the
observations concerning the effects of this modality on the normal tissues. Since
qualitatively the reactions may be similar i t is critical to quantitate as much as possible
both tumor regression and normal tissue injury.
In regard to normal tissue response, Moritz and Henriques (17) demonstrated that skin
In contact with hot water would suffer severe damage once a critical temperature had been
reached. Similar observations have been noted in the tails of baby rats immersed in hot
water. The authors calculated that an increase of only 20% in heating time or less than
.5° C at the critical temperature would enhance the probability of tissue necrosis from
zero to .100%. This underlines the importance of the need for accurately measuring the
temperature and to deliver uniform temperature in the volume treated in clinical
applications.
The reduction In dose of irradiation combined with heat to produce the same biological
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effect has been defined as thermal enhancement ratio (TER). I f there is greater TER in
tumor than normal tissues the differences is defined as therapeutic gain factor (TGF).
Unfortunately, before an optimal clinical use of heat can be accomplished there are
a number of technological problems related to heating sources, clinical thermometry and
definition of a variety of treatment factors which may influence the effects of this
modality alone or combined with irradiation which will require a great deal of effort in
development and well designed clinical t r i a l s .
The currently existing hyperthermia modalities, microwave, radiofrequency and
ultrasound have inherent advantages and disadvantages which have been summarized by other
authors (18). At the present time a major obstacle to clinical application of heat is the
inability to deliver adequate and homogeneous temperatures to deep seated tumors (3 cm
penetration of 915 MHz and 4 cm for 433 MHz microwave). Lower frequencies (27 MHz) may
provide better depth temperature but heat deposition is diffuse and cannot be localized
to small volumes.
Also, invasive thermometry must be used with each application, which represents some
discomfort to the patient. In addition, hyperthermia with ultrasound cannot be carried
out with deep seated tumors unless they are near a natural hollow viscera, such as the
esophagus, bladder, rectum etc. Furthermore, only a few points of temperature can be
measured. This is unsatisfactory, since we know that in steady state phantoms the thermal
distribution is not homogeneous. In addition, there is a decreased temperature in the
depth of the tissues, due to absorption and dissipation (18). Also, the intricacies of
the relationship between microcirculation, blood flow and temperature distribution have
just begun to be explored (19).
Among the biologically related events that have significant impact in clinical
application of heat are the following:
1.

Temperature and time of heat exposure.

In vitro and in vivo experiments have demonstrated that there is a greater degree of
cell k i l l with increasing temperatures, particularly above 42° C. The time of exposure
to heat and the temperature are closely interrelated. According to Henriques (20) over
43.5 C the effect of increased temperature of 1° c is equivalent to a decrease in heating
time by a factor of two (and vice versa).
2. Fractionation and thermal tolerance or resistance.
Henle and Leeper (21) have demonstrated in vitro that fractionated hyperthermia may
result in thermal tolerance, which can be represented as an increase in the Do of a
subsequent hyperthermia survival curve which has been distinguished from the repair of
sublethal heat damage reflected as a return of the shoulder (21,22). The time for
development of maximal thermal tolerance and the level of this phenomenon depend upon the
degree of damage induced by the f i r s t heat treatment (23,24). Thermal tolerance has been
observed in most cultured mammalian cells and in all normal tissues evaluated. Thermal
tolerant cells may be more resistant to irradiation (21,25,26), which makes this even a
more important problem when both modalities are combined.
As noted by Field and Bleehen (12) low heating times at moderate temperatures may
induce thermal resistance, which could have a profound clinical affect.
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3.

Sequential administration of heat and irradiation.

Overgaard and Overgaard (27) observed in a mouse mammary carcinoma treated with
27 MHz microwave that the central portion of the tumor was more severely damaged than the
periphery. This would support the use of combined irradiation and heat, hyperthermia
being especially effective against centrally located hypoxic cells system to irradiation
and irradiation eliminating the tumor cells in the periphery of the tumor, where heat
would be less effective.
Dewey et a l . (10) and Sapareto (28) have shown that cells at low pH are less efficient
in repairing sublethal heat damage which can interact with sublethal radiation damage.
These authors have shown in cells in vitro that when heat and irradiation are administered
together there is a greater cell k i l l than when heat is delivered more than 30 minutes
before or after administration of the irradiation. When the two modalities are combined
the increased cell killing follows the pattern of direct heat injury not that of
irradiation, thus the effect of the radioresistant S phase cells is greater than on the
more radiosensitive cells in other portions of the cell cycle (late Gl or G2 interface).
Dewey (11) has hypothesized that i f heat is delivered three hours prior to
irradiation, cells with a low pH will have minimal ability to repair heat damage and
therefore may be greatly sensitized to the affects of subsequent irradiation. In vivo
data reported by Overgaard (27) and Stewart and Denekamp (14) in animals suggests that
when the irradiation is delivered before the heat skin behaves like cells with normal pH
and tumor cells as those having low pH. However, when the heating preceeds irradiation
the data for the skin parallels that of in vitro experiments, but for tumors i t is not
reproducible.
Several preliminary reports on the clinical application of hyperthermia have been
published recently.
Hornback et a l . (7) reported on 70 patients with advanced malignant tumors of various
histological types treated with microwave radiation (433 MHz) and ionizing radiation
(doses ranging from 1100 in two weeks to 6000 rad in six weeks). Twenty-one patients
completed the planning course of treatment and were followed for a minimum of nine months.
Ninety percent experienced complete relief of symptoms and 80% exhibited complete tumor
regression. Nine of the complete responders remained free of tumor from nine to 14 months
after therapy. The combined treatment was well tolerated, without significant skin or
subcutaneous tissue Injury.
LeVeen et a l . (29) described the results in 21 patients with different malignant
neoplasias treated with radiofrequency (13.56 MHz). The authors describe tumor regression
or destruction without residual tumor at autopsy, but i t Is d i f f i c u l t to ascertain from
their publication exactly how many patients had complete or partial tumor regression and
how many have survived for extended periods of time after therapy.
Kim and Hahn (30) reported partial and transitory tumor regressions in 10 of 19
patients treated with 27.2 MHz radiofrequency Inductive heating (30 minutes, 42° C). In
contrast, the same authors observed partial or complete tumor regression in 42 of 54
patients receiving a combination of heat Immediately before irradiation (1000 to 2000 rad).
These authors reported enhanced skin reactions after this combined therapy only in
patients treated to areas Including skin grafts or extensive fibrosis from previous
surgical procedures.
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Marmor et a l . (31) reported results in 26 evaluable courses of hyperthermia in 21
patients with superficial metastatic or recurrent malignant tumors treated with a minimum
of 43 C for 30 minutes given three times weekly. Tumor response was analyzed after six
treatments. Of the lesions treated three had complete response (12%) and 11 a partial
response (42%). Squamous cell carcinoma lesions of the head and neck showed several
regressions (one complete only). There were five patients who developed small superficial
cutaneous burns that healed in seven to 10 days. There were four instances of extensive
central tumor necrosis. Ten of the 26 courses of treatment resulted in significant pain
during the ultrasound irradiation, usually subsiding after completion of the treatment.
There was no significant correlation between the temperature in the center of the tumor
and the injury to the normal tissues, except that four cases of central necrosis were
observed with temperatures above 44° C. Previous irradiation of the treated area did not
decrease the tolerance of the normal tissues to ultrasound.
^subsequent report by Marmor and Hahn (9) describe their experience on 16 patients
receiving 18 courses of irradiation with ultrasound for recurrent tumors after doses of
irradiation ranging from 4400 to 11,000 rad. Eleven of the 18 courses of ultrasound
resulted in objective tumor response (only two complete). In addition, five previously
irradiated patients were given six courses of heat plus low dose irradiation (1200 to
2400 rad). Three patients showed complete tumor response and two partial tumor regression,
suggesting that the combination of heat and irradiation was more effective than ultrasound
alone.
Recently, Bicher et a l . (32) described the preliminary results of treatment with
microwaves (frequencies of 2450, 915 and 300 MHz) for 90 minutes. The skin was cooled
by an air j e t . Tissue temperature was kept at 45° C when hyperthermia alone was used and
at 42 C in combination with radiation. Patients were treated twice a week with 72 hour
intervals between treatments. The regime consisted of four treatments of hyperthermia
alone followed by a week of rest. Thereafter each hyperthermia treatment was preceeed
by a 400 rad fraction or x-irradiation delivered in four combined treatments to a total of
1600 rad. Twenty-three patients encompassing 37 treatment fields have been entered into
the protocol. Most tumors responded to treatment, 62% of these with total disappearance;
skin, brain, breast and spinal cord are among the treated areas. Melanomas and lymphomas
are the most sensitive tumors, sarcomas the most resistant; adeno and squamous cell
carcinoma intermediate. No toxicity induced by this combination has been detected, even
in areas previously Irradiated to high doses.
Arcangeli et a l . (33) reported on a group of 15 patients with N2 and N3 multiple
cervical lymph nodes for head and neck cancer treated with multiple daily fractionation
radiotherapy (total doses of 4000-7000 rad) and local hyperthermia (2450 or 915 .MHz)
Seventeen of 20 lymph nodes (85%) treated with this combination achieved complete
regression compared with six of 13 (46%) treated with multiple fractionation irradiation
alone and 14 of 46 (30%1 with lymph nodes treated witn conservative fractionation
radiotherapy (historical controls). The authors did not observe enhanced normal tissue
reactions.
From preliminary studies i t is apparent that heat alone, or optimally combined with
irradiation has the ability to destroy tumor cells and has potential clinical application
in cancer management. However, an Intensive effort must be devoted to the development of
adequate equipment that can deliver heat to deep seated tumors, located in the thorax,
abdomen or pelvis. Even though ultrasound has definite advantages over radiofrequency of
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microwave in terms of depth of penetration, a major obstacle faced by this modality is the
reduction and absence of penetrability Induced by air tissue or tissue bone interfaces.
Furthermore, dosimetric observations have documented the lack of uniformity in heat
distribution with some modalities and applicators as well as the non-uniform distribution
of heat in most tumors. Stringent quality control programs in hyperthermia, like the
irradiation must be designed to enhance the accuracy of determination of heat absorption
in tissues and to monitor the temperature at various sites throughout the administration
of hyperthermia. The Radiation Therapy Oncology Group is developing a collaborative
hyperthermia physics reference center to provide the standards for dosimetry in clinical
trials conducted by this group. In addition, major efforts and funds should be devoted to
the design and development of invasive and non-invasive clinical thermometry technology.
Since i t is extremely d i f f i c u l t to do in situ measurements at multiple sites in deep
seated tumors, non-invasive thermometry techniques must be developed in appropriate models,
so that only a few reference points, such as in the surface and the center of the tumor,
when clinically feasible, should be carried out with every treatment. As the advances in
technology evolve I t will be important to continue clinical trials to determine the
optimal schemas for administration of heat and irradiation or drugs to achieve the
maximum therapeutic gain.
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FIGURE lA

Recurrent epidermoid carcinoma of the scalp treated with heat alone. Most of the
tumor underwent complete regression but persistent nodule at the margin was treated with
4500 rad TD in 15 fractions, three weeks with superficial x-rays (120 KV, .3 mm cu HVL).
FIGURE IB

Photograph seven months after treatment showing complete regression of tumor.
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FIGURE 2A

Pretreatment photograph of two large ulcerated metastatic nodules (4 cm in diameter)
in the leg. The upper lesion was treated with a combination of irradiation (5000 rad in
11 fractions) and hyperthermia. The lower lesion was treated with the same dose of
irradiation but without heat.
FIGURE 2B
1

Photograph six months after therapy, showing over 90% regression of the tumors.
The lower lesion, treated with irradiation alone recurred shortly thereafter.
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